Discovery and preliminary structure–activity relationship studies of novel benzotriazine based compounds as Src inhibitors
Authors:
- Glenn NoronhaGNGlenn Noronha
- Kathy BarrettKBKathy Barrett
- Jianguo CaoJCJianguo Cao
- Elena DneprovskaiaEDElena Dneprovskaia
- Richard FineRFRichard Fine
- Xianchang GongXGXianchang Gong
- Colleen GritzenCGColleen Gritzen
- John HoodJHJohn Hood
- Xinshan KangXKXinshan Kang
- Boris KlebanskyBKBoris Klebansky
- G. LiGLG. Li
- W. LiaoWLW. Liao
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (21) , 5546-5550
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Src Inhibitors as Potential Therapeutic Agents for Human CancersMini-Reviews in Medicinal Chemistry, 2006
- A renaissance for SRCNature Reviews Cancer, 2004
- Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarctionJournal of Clinical Investigation, 2004
- Src family kinases in tumor progression and metastasisCancer and Metastasis Reviews, 2003
- Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasivenessSurgery, 2003
- Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian CancersGynecologic Oncology, 2003
- Src deficiency or blockade of Src activity in mice provides cerebral protection following strokeNature Medicine, 2001
- Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?Trends in Pharmacological Sciences, 2000
- Role of Src expression and activation in human cancerOncogene, 2000
- Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.Journal of Clinical Investigation, 1993